Normal ABL1 is a tumor suppressor and therapeutic target in human and mouse leukemias expressing oncogenic ABL1 kinases
scientific article published on 10 February 2016
Author/s
author: Heiko van der Kuip, Sabine Cerny-Reiterer, Margaret Nieborowska-Skorska, Grażyna Hoser, Elisabeth Bolton-Gillespie, Markus Müschen, Tomasz Stokłosa, Oliver Hantschel, Peter Valent, Mariusz A Wasik, Barbara Górnicka, Christine Richardson, Tomasz Skórski, Mateusz Koptyra
Work details
Copyright status
Copyright status information is not available for this work. The copyright status depends on the jurisdiction, the author's date of death and the date the work was created or published.
To learn more about copyright terms in different countries, visit the countries and terms page.